Dr. Jennifer Johnson

Medical Science Director at Mitsubishi Tanabe Pharma America. #ALS EPTX➡️HTX. Salsa dancer💃🏻. Views my own.

[Dr. Jennifer Johnson @brainychickJ]

Big news! I have accepted a position @MTPA_US as a Medical Science Director focusing on their ALS and PD pipeline. With one of only two FDA-approved interventional drugs for ALS, MTPA is truly committed to improving patient lives and I’m thrilled to be joining an amazing team!

[Dr. Jennifer Johnson @brainychickJ]

@Gabriel_E_VV @WashUNeurology Congrats Gabe! They are lucky to have you! Will you be attending the upcoming International MDS congress in Philly? If so, we should catch up!

[Dr. Jennifer Johnson @brainychickJ]

@KPRC2 It is still not accurate @KPRC2!!!!!! Over 500 homes in First Ward are without power and the map says we are fully energized. Is there ANYONE that can provide us with accurate information?! People are dying!!!

[Dr. Jennifer Johnson @brainychickJ]

@KHOU @KHOU @CenterPoint My phone number appears to be blocked when I call the 713-207-2222 number for updates. Calls from another phone go through without issue. Can you please explain why this is happening?

[Dr. Jennifer Johnson @brainychickJ]

@KHOU It is still not accurate @KHOU !!!!!! Over 500 homes in First Ward are without power and the map says we are fully energized. Is there ANYONE that can provide us with accurate information?! People are dying!!!

[Dr. Jennifer Johnson @brainychickJ]

My tweet was quoted in this Newsweek article! https://t.co/eMUXcsiggu

[Dr. Jennifer Johnson @brainychickJ]

After 12 years in Houston, it’s time to go. The derecho and Beryl show our city’s unpreparedness. The lack of transparency on power restoration during a heat advisory proves nothing is being done to weatherize infrastructure. Shame on you @CenterPoint @GregAbbott_TX @DanPatrick

[Dr. Jennifer Johnson @brainychickJ]

@academic_exit Medical Science Director,
Med Affairs in Pharma

[Dr. Jennifer Johnson @brainychickJ]

Excited to be attending the @alsagoldenwest 13th Annual California ALS Research Summit and Champions for Cures and Care gala Jan. 20-21, 2023 in San Francisco. If attending, let me know, would love to meet you!

[Dr. Jennifer Johnson @brainychickJ]

@academic_exit Yes, I make more than 3X as much as I did as a postdoc, and in addition benefits, up to 20% annual bonus and 20% cash LTI

[Dr. Jennifer Johnson @brainychickJ]

@academic_exit Cheeky Scientist: https://t.co/oEbxEgiRo3 I joined and within two months I landed my first industry job as a medical science director. Many of my friends who also joined had similar success stories!

[ALS News Today @alsnewstoday]

An oral formulation of edaravone, Radicava Oral suspension, has been approved in Canada for treating amyotrophic lateral sclerosis. https://t.co/3IhWcLxpH2

#ALS #ALSNewsToday #amyotrophiclateralsclerosis #livingwithALS

[Dr. Jennifer Johnson @brainychickJ]

Real-World Data Analysis of Survival with RADICAVA
Press release: https://t.co/FNt21wVVZa

[ALS News Today @alsnewstoday]

Post-hoc analysis showed slower progression in ALS patients on Radicava (edaravone), including those low FVC values; early start supported. https://t.co/3D14OcaQUH

#ALS #ALSNewsToday #amyotrophiclateralsclerosis #livingwithALS #ALScommunity #ALSadvocacy

[Dr. Jennifer Johnson @brainychickJ]

This is a game-changer. Congrats to the team @MTPA_US and importantly, thank you to all the people with ALS who participated in the trials. Without them, this would not have been possible! There is still work to do- until we have a cure, we won’t stop.

[U.S. FDA @US_FDA]

Today we approved an oral treatment for adults with ALS, commonly referred to as Lou Gehrig’s disease.

ALS is a rare disease that attacks and kills the nerve cells that control voluntary muscles.

Learn more about this approval: https://t.co/OLa69EPzRT

[Tanabe Pharma America @TanabePharmaUS]

Real-world data (#RWD) is one way MTPA learns how #ALS impacts patients and their families. RWD can lead to new discoveries that help ALS treatments.

[Tanabe Pharma America @TanabePharmaUS]

We’re pleased to announce an important update on our development program. Read more here:

[Dr. Jennifer Johnson @brainychickJ]

I am thrilled to be hosting @MichelleJoLo1 tomorrow at our BCM Neuroscience department seminar! More work is needed to foster an inclusive environment in research but we wouldn't be where we are today without Dr. Jones-London. Let's bring diverse and creative minds to the table!

[BCM Department of Neuroscience @bcm_neurosci]

We have another great seminar planned tomorrow (9/24) at 11am CT and all are welcome! Very excited to hear from @NINDSDiversity Chief, Dr. Michelle Jones-London, who will discuss strategies for enhancing the #diversity of #neuroscience researchers! https://t.co/THn1Yucicd

[Dr. Jennifer Johnson @brainychickJ]

@constanza343 That sounds like a pretty good problem to have! Congrats!!! 🎊🎉🍾

[Dr. Jennifer Johnson @brainychickJ]

@SheridadeLeeuw Awesome! Congratulations!!! 🎉🍾🎈